364 related articles for article (PubMed ID: 25715768)
1. Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer.
Yoon SH; Choi YD; Oh IJ; Kim KS; Choi H; Chang J; Shin HJ; Park CK; Kim YC
Cancer Res Treat; 2015 Oct; 47(4):661-9. PubMed ID: 25715768
[TBL] [Abstract][Full Text] [Related]
2. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing.
Yeo CD; Kim JW; Kim KH; Ha JH; Rhee CK; Kim SJ; Kim YK; Park CK; Lee SH; Park MS; Yim HW
Lung Cancer; 2013 Aug; 81(2):207-12. PubMed ID: 23726527
[TBL] [Abstract][Full Text] [Related]
3. Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
Kim HJ; Lee KY; Kim YC; Kim KS; Lee SY; Jang TW; Lee MK; Shin KC; Lee GH; Lee JC; Lee JE; Kim SY
Lung Cancer; 2012 Mar; 75(3):321-5. PubMed ID: 21930325
[TBL] [Abstract][Full Text] [Related]
4. Peptide Nucleic Acid Clamping and Direct Sequencing in the Detection of Oncogenic Alterations in Lung Cancer: Systematic Review and Meta-Analysis.
Song JU; Lee J
Yonsei Med J; 2018 Mar; 59(2):211-218. PubMed ID: 29436188
[TBL] [Abstract][Full Text] [Related]
5. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity.
Han HS; Lim SN; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Son SM; Choi SY; Lee HC; Lee OJ
J Thorac Oncol; 2012 Feb; 7(2):355-64. PubMed ID: 22157369
[TBL] [Abstract][Full Text] [Related]
6. Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma.
Kim HS; Sung JS; Yang SJ; Kwon NJ; Jin L; Kim ST; Park KH; Shin SW; Kim HK; Kang JH; Kim JO; Park JY; Choi JE; Yoon H; Park CK; Yang KS; Seo JS; Kim YH
PLoS One; 2013; 8(12):e81975. PubMed ID: 24376508
[TBL] [Abstract][Full Text] [Related]
7. Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.
Won JK; Keam B; Koh J; Cho HJ; Jeon YK; Kim TM; Lee SH; Lee DS; Kim DW; Chung DH
Ann Oncol; 2015 Feb; 26(2):348-54. PubMed ID: 25403583
[TBL] [Abstract][Full Text] [Related]
8. Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.
Wang MC; Wang CL; Chen TL; Chang JW; Lu JJ; Chang PY; Chiou CC
Clin Chem Lab Med; 2017 Oct; 55(12):1979-1986. PubMed ID: 28787267
[TBL] [Abstract][Full Text] [Related]
9. Reliable detection of rare mutations in EGFR gene codon L858 by PNA-LNA PCR clamp in non-small cell lung cancer.
Skronski M; Chorostowska-Wynimko J; Szczepulska E; Szpechcinski A; Rudzinski P; Orlowski T; Langfort R
Adv Exp Med Biol; 2013; 756():321-31. PubMed ID: 22836650
[TBL] [Abstract][Full Text] [Related]
10. Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study.
Min KW; Kim WS; Jang SJ; Choi YD; Chang S; Jung SH; Kim L; Roh MS; Lee CS; Shim JW; Kim MJ; Lee GK;
QJM; 2016 Mar; 109(3):167-73. PubMed ID: 26031706
[TBL] [Abstract][Full Text] [Related]
11. PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer.
Han JY; Choi JJ; Kim JY; Han YL; Lee GK
BMC Cancer; 2016 Aug; 16():627. PubMed ID: 27519791
[TBL] [Abstract][Full Text] [Related]
12. Detection of low-level EGFR T790M mutation in lung cancer tissues.
Oh JE; An CH; Yoo NJ; Lee SH
APMIS; 2011 Jul; 119(7):403-11. PubMed ID: 21635547
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
Nagai Y; Miyazawa H; Huqun ; Tanaka T; Udagawa K; Kato M; Fukuyama S; Yokote A; Kobayashi K; Kanazawa M; Hagiwara K
Cancer Res; 2005 Aug; 65(16):7276-82. PubMed ID: 16105816
[TBL] [Abstract][Full Text] [Related]
14. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
Cho MC; Choi CM; Kim S; Jang S; Jang S; Park CJ; Chi HS; Peyton MJ; Lee W; Chun S; Kim SW; Min WK
Clin Chem Lab Med; 2011 Sep; 50(3):565-72. PubMed ID: 21899495
[TBL] [Abstract][Full Text] [Related]
15. Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.
Kim HR; Lee SY; Hyun DS; Lee MK; Lee HK; Choi CM; Yang SH; Kim YC; Lee YC; Kim SY; Jang SH; Lee JC; Lee KY
J Exp Clin Cancer Res; 2013 Aug; 32(1):50. PubMed ID: 23927790
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.
Su KY; Chen HY; Li KC; Kuo ML; Yang JC; Chan WK; Ho BC; Chang GC; Shih JY; Yu SL; Yang PC
J Clin Oncol; 2012 Feb; 30(4):433-40. PubMed ID: 22215752
[TBL] [Abstract][Full Text] [Related]
17. Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment response.
Park HY; Oh HJ; Kim KH; Kim TO; Park CK; Shin HJ; Lim JH; Kwon YS; Oh IJ; Kim YI; Lim SC; Kim YC; Choi YD
Thorac Cancer; 2016 Nov; 7(6):639-647. PubMed ID: 27755804
[TBL] [Abstract][Full Text] [Related]
18. Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients.
Shin S; Kim J; Kim Y; Cho SM; Lee KA
Clin Chem Lab Med; 2017 Oct; 55(12):1962-1969. PubMed ID: 28306520
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.
Lim SH; Lee JY; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2014 Apr; 9(4):506-11. PubMed ID: 24736073
[TBL] [Abstract][Full Text] [Related]
20. Ultrasensitive and quantitative detection of EGFR mutations in plasma samples from patients with non-small-cell lung cancer using a dual PNA clamping-mediated LNA-PNA PCR clamp.
Zhang S; Chen Z; Huang C; Ding C; Li C; Chen J; Zhao J; Miao L
Analyst; 2019 Feb; 144(5):1718-1724. PubMed ID: 30663747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
